Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
1997 2
1998 3
1999 2
2000 4
2001 4
2002 2
2004 3
2005 2
2006 4
2007 5
2008 3
2009 3
2010 2
2011 3
2012 3
2013 1
2014 4
2015 1
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression.
Bourguignon LY. Bourguignon LY. Int J Mol Sci. 2016 Apr 7;17(4):517. doi: 10.3390/ijms17040517. Int J Mol Sci. 2016. PMID: 27070574 Free PMC article. Review.
Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions.
Bourguignon LY. Bourguignon LY. Am J Pathol. 2014 Jul;184(7):1912-9. doi: 10.1016/j.ajpath.2014.03.010. Epub 2014 May 9. Am J Pathol. 2014. PMID: 24819962 Free PMC article. Review.
Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.
Wang SJ, Bourguignon LY. Wang SJ, et al. Am J Pathol. 2011 Mar;178(3):956-63. doi: 10.1016/j.ajpath.2010.11.077. Am J Pathol. 2011. PMID: 21356346 Free PMC article. Review.
Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
Bourguignon LY, Shiina M, Li JJ. Bourguignon LY, et al. Adv Cancer Res. 2014;123:255-75. doi: 10.1016/B978-0-12-800092-2.00010-1. Adv Cancer Res. 2014. PMID: 25081533 Free PMC article. Review.
CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression.
Bourguignon LY. Bourguignon LY. J Mammary Gland Biol Neoplasia. 2001 Jul;6(3):287-97. doi: 10.1023/a:1011371523994. J Mammary Gland Biol Neoplasia. 2001. PMID: 11547898 Review.
Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.
Bourguignon LY. Bourguignon LY. Semin Cancer Biol. 2008 Aug;18(4):251-9. doi: 10.1016/j.semcancer.2008.03.007. Epub 2008 Mar 26. Semin Cancer Biol. 2008. PMID: 18450475 Free PMC article. Review.
CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
Bourguignon LY, Zhu D, Zhu H. Bourguignon LY, et al. Front Biosci. 1998 Jul 1;3:d637-49. doi: 10.2741/a308. Front Biosci. 1998. PMID: 9634539 Review.
Identification of novel drugs to target dormant micrometastases.
Hurst RE, Hauser PJ, You Y, Bailey-Downs LC, Bastian A, Matthews SM, Thorpe J, Earle C, Bourguignon LY, Ihnat MA. Hurst RE, et al. BMC Cancer. 2015 May 14;15:404. doi: 10.1186/s12885-015-1409-4. BMC Cancer. 2015. PMID: 25971923 Free PMC article.
Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.
Bourrguignon LY, Iida N, Welsh CF, Zhu D, Krongrad A, Pasquale D. Bourrguignon LY, et al. J Neurooncol. 1995 Dec;26(3):201-8. doi: 10.1007/BF01052623. J Neurooncol. 1995. PMID: 8750186 Review.
The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer.
Chan JK, Blansit K, Kiet T, Sherman A, Wong G, Earle C, Bourguignon LY. Chan JK, et al. Gynecol Oncol. 2014 Mar;132(3):739-44. doi: 10.1016/j.ygyno.2014.01.034. Epub 2014 Jan 25. Gynecol Oncol. 2014. PMID: 24472409
50 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page